Science Articles

One disease stopping another? That’s cancer we’re talking about

Can molecular biological research of rare genetic disorders help provide keys to understanding cancer and other illnesses

One disease stopping another? That's cancer we're talking about

Science is still divided at the core into the main domains as we know them, Physics, Chemistry, and Biology. But then, when we take into consideration the recent developments that have taken place in all these forms in the last few decades, a lot of avenues have been opening up. It is surely not so huge a surprise to see extensive research being carried out in all these fields even today. This is done to expand our field of knowledge and to seek answers about problems that plague us even today.

What is Molecular Biology?

A field that branched out in the not so recent past is molecular biology. Essentially, this encompasses the study of the structural and compositional aspects of cellular molecules and the way they interact with each other to get out normal life processes. At the root of all vital processes that occur in living organisms lies the study of molecular biology. This extensive study and years of research have led us into paths that have never been trodden before. This helps us in understanding the lethal disease cancer among other potentially fatal illnesses. One such rate Genghis disease that is being monitored and studied extensively through molecular biology research is the Laron Syndrome.

What is the Laron Syndrome?

The Laron syndrome is essentially a condition of the body wherein the body is no longer able to utilise the growth hormone properly. This results in primarily the pretty much obvious consequence – short stature. The disease is also named the Laron-type dwarfism. It is an autosomal recessive Didier, that is generally triggered by a mutant receptor of the growth hormone – somatotropin. Another effect of this disease is the increased sensitivity to insulin. However, this effect of the disease seems to have more beneficial effects that the bad ones. As a matter of fact, with heightened insulin sensitivity, the affected person would be much less likely to develop the diabetes mellitus type 2 disease, and quite surprisingly, even cancer. Strikingly low rates of cancer have been observed with people affected by this syndrome. Diabetes is no exception too.

However, the short stature has inevitably increased the risk of death from accidental causes for the affected people. This discovery truly provides us with the key to unlocking the mysteries of cancer and other such potentially fatal diseases. The study and extensive molecular biological research of such rate genetic disorders have led us to believe in today’s world with current developments.